Menactra discontinued 2024?

Was Menactra discontinued in 2024?

Yes. Menactra (meningococcal conjugate vaccine, usually cited for protection against MenACWY) was discontinued in 2024 in the U.S., and manufacturing/distribution was stopped at that time [1].

What does “discontinued” mean for patients and providers?

A discontinued vaccine is no longer being supplied/produced. That means clinics typically can’t place new vaccine orders for Menactra and must use an alternative meningococcal conjugate product when indicated [1].

What can be used instead?

When Menactra is not available, healthcare providers use the available meningococcal ACWY conjugate vaccine options in the same age indications (the specific substitute depends on what’s stocked and the patient’s schedule) [1].

Will people who already started the series need to switch?

If a patient is mid-series, clinicians determine the correct next dose using the current available product and the guidance used for interchangeability/scheduling in their practice setting [1].

Where can you confirm the latest availability?

The most reliable source is the most current manufacturer and U.S. supply/discontinuation information, which is reflected in drug availability databases and vaccine notices that track discontinued products and remaining stock status [1].

Sources:
[1] https://www.drugs.com/discontinued.html